ACTSI Investigator Dr. Jack Arbiser in the News

Jack Arbiser, MD, PhD, ACTSI investigator and professor of Dermatology, Emory University School of Medicine and Chief of Service, Atlanta VAMC

Nature Medicine | Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity
March 28, 2011

Emory News Center | Singing the Blues for Aggressive Brain Tumors
March 28, 2012

Science Translational Medicine | Anti-Invasive Adjuvant Therapy with Imipramine Blue Enhances Chemotherapeutic Efficacy Against Glioma
March 28, 2012

Georgia Tech News Center | Novel Compound Halts Tumor Spread, Improves Brain Cancer Treatment in Animal Studies
March 28, 2012

YouTube | TEDxGeorgiaTech: Technology to dance with nature...
May 12, 2012

Emory Health Now Blog | Magnanimous magnolias keep on giving
September 7, 2011

Emory/Children's Pediatric Research Center's Center for Pediatric Nanomedicine awarded Dr. Arbiser an award to support Novel Anti-inflammatory Nanocarriers for Spinal Cord Injury.

Upcoming Events

View All Events

Latest News

Training

ACTSI-supported OculoStaple Wins Again

Atlanta Clinical & Translational Science Institute (ACTSI)-supported team, OculoStaple wins second place in the 2015 InVenture Prize at Georgia Tech. Team members Jackie Borinski, Mohamad Ali Najia, and Drew Padilla, all biomedical...

Discovery

Infographic: What are the Phases of Clinical Trials?